Get access

Monoclonal gammopathy of undetermined significance (MGUS) in patients with psoriasis may be associated with long-term treatment with efalizumab, but not with anti-TNF-α treatments or ustekinumab

Authors


No abstract is available for this article.

Get access to the full text of this article

Ancillary